Compounds > triethylenemelamine
Page last updated: 2024-11-06

triethylenemelamine and Granulocytic Leukemia, Chronic

triethylenemelamine has been researched along with Granulocytic Leukemia, Chronic in 3 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SLIPYAN, A1
BETHELL, FH1
GRIZZLE, JE1

Other Studies

3 other studies available for triethylenemelamine and Granulocytic Leukemia, Chronic

ArticleYear
Unusual toxicity to triethylene melamine in a case of chronic myelogenous leukemia.
    Annals of internal medicine, 1953, Volume: 38, Issue:2

    Topics: Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Triethyleneme

1953
Myleran and triethylene melamine in the treatment of chronic granulocytic leukemia.
    Annals of the New York Academy of Sciences, 1958, Apr-24, Volume: 68, Issue:3

    Topics: Busulfan; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Triethylene

1958
MULTIVARIATE COMPARISON OF RESULTS OF TREATMENT IN CHRONIC LYMPHOCYTIC AND CHRONIC GRANULOCYTIC LEUKEMIA.
    Journal of chronic diseases, 1964, Volume: 17

    Topics: Antineoplastic Agents; Blood Platelets; Busulfan; Chlorambucil; Factor Analysis, Statistical; Hemogl

1964